End stage kidney disease (hemodialysis)
Conditions
Interventions
None listed
Sponsors
Nara Medical University Department of Nephrology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with end-stage kidney disease receiving maintenance dialysis at the participating dialysis clinics
Exclusion criteria
Exclusion criteria: Patients who are determined to be inappropriate for participation in this study by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality Death due to cardiovascular disease, infectious disease, and malignancy | — |
Secondary
| Measure | Time frame |
|---|---|
| Congestive heart failure, coronary artery disease, cerebral hemorrhage, cerebral infarction, subarachnoid hemorrhage, obstructive arteriosclerosis, fracture, vascular access-related complications, Performance Status | — |
Countries
Japan
Contacts
Public ContactKaori Tanabe
Nara Medical University Department of Nephrology
Outcome results
None listed